On Thursday evening, US President Trump said he would “hit Iran hard tonight”. Then, as the world waited with bated breath, came the announ...

There are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...

India has seen a significant rise in Foreign Direct Investment, attracting USD 843 billion between 2014-15 and 2025-26. Key government init...

Just look at developments in the past 48 hours. The war between Iran and Israel resumed, but within hours Tehran said it had halted all off...

Even in normal times it is futile to try and guess the outcome of most global events. But in the New World Order, it makes no sense at all ...

For the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...

There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...

Has a peace deal been agreed on by the US and Iran? Will the fragile ceasefire hold? No one can answer these questions with any certainty. ...

If the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...

Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...

In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...

Hindustan Laboratories has received Sebi's observations, a crucial step towards its IPO, which includes a fresh issue and an offer for sale...

Excise officials in Hyderabad arrested a former software engineer for cultivating cannabis plants on his terrace. Investigators linked the ...

Government is looking at the financial viability for providing Rs 200 crore each to three new bulk drug manufacturing parks, Parliament was...

"We are importing 70-80 per cent bulk drugs from China. We will shortly come out with strategies to improve our bulk drug capacity in India.

Andhra Pradesh government has lifted a ban on the expansion of bulk drug manufacturing facilities imposed six years ago to curb pollution.

The department of pharmaceuticals has asked the National Pharmaceutical Pricing Authority (NPPA) to clear price revision applications recei...